Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    Prof. Pierre Guertin

    Prof. Pierre Guertin
    Laval University, Canada
    Email: pierre.guertin@crchudequebec.ulaval.ca
    Tel: +1 418-525-4444, pos
    Fax: +1 418-654-2753

    More Info.

    Editorial Board

    Agata Paneth
    Department of Organic Chemistry
    Medical University of Lublin
    Poland
    agata.paneth@umlub.pl
    IJPSDR

    Research Interest: Medicinal chemistry, Structure-activity relationship studies, Synthesis of heterocyclic compounds, Antimicrobial screening, Enzymatic studies.


    More Info.
    Nian-Qiu Shi
    Department of Pharmaceutics School of Pharmacy Ji Lin Medical College
    China
    shinianqiu2009@163.com
    IJPSDR

    Research Interest: Targeting drug delivery systems (TDDS), Multifunctional nanocarriers or macromolecules have many advantages for diseases treatments. Our lab employs diverse targeting delivery systems including conjugate, liposomes and micelles to deliver anticancer drug or gene for tumor therapy. In this process, we unitize stimuli-responsive strategies (e.g. enzyme-responsive) to obtain the targeting therapy of tumor. Cell-penetrating peptides (CPPs) are also adopted to cross cellular barriers. Internalization mechinisms of CPPs or CPP-cargoes are also focused by us.

    More Info.
    Sara Malo
    Department of Microbiology, Medicine
    University of Zaragoza
    Spain
    smalo@unizar.es
    IJPSDR

    Research Interest: Pharmacoepidemiology, Drug utilization and factors related, Appropriateness, Adherence to clinical guidelines, Effectiveness, Variability.

    More Info.
    Mohammad-Ali Shahbazi
    Division of Pharmaceutical Technology
    University of Helsinki
    Finland
    m.a.shahbazi@helsinki.fi
    IJPSDR

    Research Interest: Biomaterials, Nanomedicine, Pharmaceutical Nanotechnology, Nanovaccines, Targeted drug delivery, Nanotoxicity, surface biofunctionalization, Cell-nanoparticle Interactions.

    More Info.
    BEATA SARECKA-HUJAR
    phd
    Department of Pharmaceutical Technology
    Medical University of Silesia in Katowice
    Poland
    beatasarecka@poczta.onet.pl
    IJPSDR

    After graduation I started to work at Medical University of Silesia, where I completed my PhD thesis on genetic polymorphisms in coronary artery disease. Selected risk factors for development of arterial ischemic stroke in children were also in the area of my scientific interests. Besides, I am also interested in diagnosis and treatment of other neurological disorders in children: schizencephaly, headache, epilepsy and cerebral palsy. Nine years ago, when I moved to the Department of Pharmaceutical Technology I started the research concerning the technology for the manufacturing and optimization of micro- and nanocarriers of active substances. In addition, I am involved in analyses of rheological parameters of semi-solid preparations.


    Research Interest: developmental neurology, neuroscience, genetics, pharmaceutical technology, nanotechnology, biochemistry

    Grants: I participated in a multi-center Polish scientific grant and in several academic grants. In 2017, I was a supervisor of a grant of Medical University of Silesia regarding the release of active substances from semi-solid bases.


    List of Publications:
    Selected articles of my authorship:
    1. Beata Sarecka-Hujar, Ilona Kopyta. Poststroke epilepsy: current perspectives on diagnosis and treatment. Neuropsychiatr.Dis.Treat. 2019; Vol.15, p.95-103

    2. Joanna Sordyl, Ilona Kopyta, Beata Sarecka-Hujar, Tomasz Francuz, Paweł Matusik, Ewa Małecka-Tendera. Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. Arch.Med.Sci. 2019; Vol.15, No.1, p.120-125

    3. Beata Sarecka-Hujar, Andrzej Jankowski, Aneta Ostróżka-Cieślik, Radosław Balwierz, Anna Banyś, Renata Dyja, Dariusz Łukowiec, Dominik Marciniak, Janusz Pluta. Assessment of release of trimetazidine hydrochloride from orally disintegrating tablets (ODTs) prepared using different disintegrants. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.697-704

    4. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Tomasz Krzykawski, Jagna Karcz, Anna Banyś, Andrzej Jankowski. Application of selected diffractive and microscopic methods to evaluate the physical state of drug and morphology of microspheres obtained by spray drying of furosemide with Eudragit L30 D-55. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.759-765

    5. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek. Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta.analysis. Clin.Exp.Med. 2018; Vol.18, No.3, p.337-345. 

    6. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Andrzej Jankowski. Physicochemical characteristics of furosemide incorporated Eudragit microspheres formulated by spray drying. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.6, p.1369-1376

    7. Beata Sarecka-Hujar, Radosław Balwierz, Aneta Ostróżka-Cieślik, Renata Dyja, Dariusz Łukowiec, Andrzej Jankowski. Scanning electron microscopy and X-ray energy dispersive spectroscopy - useful tools in the analysis of pharmaceutical products. J.Phys.: Conf.Series 2017; Vol.931, 012008, p.1-5

    8. Andrzej Jankowski, Renata Dyja, Beata Sarecka-Hujar. Dermal and transdermal delivery of active substances from semisolid bases. Indian J.Pharmaceut.Sci. 2017; Vol.79, No.4, p.488-500

    9. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. The use of nanotechnology in modern pharmacotherapy. In: Multifunctional systems for combined delivery, biosensing and diagnostics. / Editors: Alexandru Mihai Grumezescu, Amsterdam: Elsevier Inc., 2017, p. 139-158, ISBN: 978-0-323-52725-5

    10. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. Perspectives of the carbon nanoparticles use in cancer therapy and imaging. Post.Biol.Kom. 2017; T.44, nr 2, s.171-184

    11. Dorota Raczkiewicz, Beata Sarecka-Hujar, Alfred Owoc, Iwona Bojar. Cognitive functions and serum cortisol concentration in perimenopausal and postmenopausal women working non-manually. Neuroendocrinol.Lett. 2017; Vol.38, No.4, p.269-274

    12. Dorota Raczkiewicz, Alfred Owoc, Beata Sarecka-Hujar, Iwona Bojar. Pain involving the motor system and serum vitamin D concentration in postmenopausal women working in agriculture. Ann.Agric.Environ.Med. 2017; Vol.24, No.1, p.151-155

    13. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek, J. Sordyl. Association between the 20210G>A prothrombin gene polymorphism and arterial ischemic stroke in children and young adults - two meta-analyses of 3586 cases and 6440 control subjects in total. Pediatr.Neurol. 2017; Vol.69, p.93-101

    14. Beata Sarecka-Hujar, Aneta Ostróżka-Cieślik, Anna Banyś. Determinants of telemedicine development in health care system. Ann.Acad.Med.Siles. 2016; Vol.70, s.214-219

    15. Ilona Kopyta, Paweł Niemiec, Anna Balcerzyk, Ewa Emich-Widera, Ewa Pilarska, Karolina Pienczk-Recławowicz, Marek Kaciński, Janusz Wendorff, Tomasz Nowak, Tomasz Iwanicki, Beata Sarecka-Hujar, Iwona Żak. Fibrinogen alpha and beta gene polymorphisms in pediatric stroke - Case-control and family based study. Eur.J.Paediatr.Neurol.2015; Vol.19, No.2, p.176-180

    16. Ilona Kopyta, Mikołaj Zimny, Beata Sarecka-Hujar. The role of biochemical risk factors in the etiology of AIS in children and adults. Int.J.Neurosci.2015; Vol.125, No.12, p.875-884

    17. Anna Banyś, Beata Sarecka-Hujar, Andrzej Jankowski, Monika Zalewska. Impact of base type on diclofenac sodium release from semi-solid dosage forms. Ann.Acad.Med.Siles. 2014; Vol.68, No.1, s.1-8

    18. Ilona Kopyta, Beata Sarecka-Hujar, Joanna Sordyl, Ryszard Sordyl. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol.Biol.Rep. 2014; Vol.41, No.7, p.4241-4251

    19. Beata Sarecka-Hujar, Iwona Żak, Ewa Emich-Widera et al. Association analysis of the E-selectin 98G>T polymorphism and the risk of childhood ischemic stroke. Cell Biochem. Funct. 2010; 28: 591-596.

    20. Ilona Kopyta, Beata Sarecka-Hujar, Ewa Emich-Widera et al. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad. Lek. 2010; 63:17-23.  

    21. Zak I, Sarecka-Hujar B, Kopyta I et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262-1267. 

    22. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117-124.


    More Info.
    Mohammed Maniruzzaman
    Researcher
    University of Greenwich
    UK
    M.Maniruzzaman@greenwich.ac.uk
    IJPSDR

    Research Interest: Drug Delivery, Continuous manufacturing, Dissolutions, Solubility, Cocrystalisation, Hot-Melt Extrusion, Particle Engineering, Medical Implants, Solid-State Analysis, PAT, QbD, Spray Drying, Process Engineering.

    More Info.
    Tanveer A Wani
    Department of Pharmaceutical Chemistry
    King Saud University
    Saudi Arabia
    twani@ksu.edu
    IJPSDR

    Research Interest: Method development and validation of biosensors for estimation of Cancer Markers.

    More Info.
    Darshana Jani
    Global Research and Development
    USA
    Darshana.Jani@pfizer.com
    IJPSDR

    Research Interest: Immunogenicity, PK, Biomarker, Regulated and non regulated bioanalysis.

    More Info.
    Tomasz Plech
    Department of Organic Chemistry
    Medical University of Lublin
    Poland
    tomasz.plech@umlub.pl
    IJPSDR

    Research Interest: Synthesis of nitrogen- and sulfur-containng heterocycles, Design and synthesis of Novel anticonvulsant, Anticancer, Antibacterial and anti-toxoplasmosis drugs, Computer-aided drug Design, Chromatographic techniques for the analysis of the newly ynthesized compounds, (Q)SAR sudies.


    More Info.
    Wei-Gang Hu
    Bio-Threat Defence Section
    DRDC Suffield Research Centre
    Canada
    Wei-Gang.Hu@drdc-rddc.gc.ca
    IJPSDR

    Research Interest: Molecular Biology, Immunology (antibodies, vaccines), and Microbiology (viruses, bacteria, and toxins).

    More Info.
    Gitali Indra
    Asst. Professor
    Department of Pharmaceutical Sciences
    Oregon State University
    USA
    indrag@onid.orst.edu
    IJPSDR

    Research Interest: Elucidate the molecular and cellular mechanisms of contribution of hair follicle stem cells in wound repair and regeneration and identify new therapeutic targets toward the goal of accelerating wound healing and to identify natural compounds that are effective against head and neck cancer.

    More Info.
    J. WARREN SALMON
    Professor
    Pharmacy
    University of Illinois
    USA
    JSJWSalmon@GMAIL.COM
    IJPSDR

    J. Warren Salmon, Ph.D. is Professor of Health Policy and Administration, School of Public Health at the University of Illinois at Chicago (UIC). He was formerly a Professor in and Head of the Department of Pharmacy Administration, College of Pharmacy; Professor of Public Policy Analysis, College of Urban Planning and Public Affairs; and Professor of Medical Education, College of Medicine at UIC.  Professor Salmon's research interests have focused on the corporatization of medicine and pharmacy, managed care pharmacy, urban health care delivery, comparative health care systems, global pharmaceutical industry developments, alternative and complimentary medicines, and selected health policy issues.  He edited Alternative Medicines:  Popular and Policy Perspectives (Tavistock/Methuen/Routledge, 1984); (with Jeffrey W. Todd) The Corporatization of Health Care: A Two Day Symposium and Public Hearing (Illinois Public Health Association, 1988); (with Eberhard Goepel) Community Participation and Empowerment Strategies in Health Promotion, 7 volumes (Zentrum fuer Interdisziplinare Forschung, 1990); The Corporate Transformation of Health Care, Part I:  Issues and Directions (Baywood, 1990); The Corporate Transformation of Health Care, Part II:  Reflections and Implications (Baywood, 1994); and (with Linda Shapiro) Health Care for Chicagoans:  How Will Health System Integration Affect the Health of the Public?  (Health & Medicine Policy Research Group, 1995).

    Research Interest: Health policy and planning; managed care pharmacy; urban health care; international health; pharmaceutical industry developments; community health promotion; public sector health services; corporatization of medicine and pharmacy.

    List of Publications:

    1.    Salmon, J.W. (2015). Time to revisit Medicare Part D?  American Health & Drug Benefits.  
    2.    Salmon, J.W. & Liu, X. M. (2015, in review). Pervasive Stigma:  HIV/AIDS Epidemic in China.  International Journal of Health Services.
    3.    Edlavitch, S.A. & Salmon, J.W. (2015). Towards an applied science of regulatory decision-making. Journal of Pharmacovigilance 3:2.
    4.    Thompson, S.L. & Salmon, J.W. (2016, Book in preparation).  Corporatization:  The Medical Malpractice Insurance Crisis and the Loss of Physician Hegemony. 
    5.    Sanchez, A.M.  & Salmon, J.W.  (2016, in preparation).  Evaluation of the pharmaceutical performance in the undertaking of professional functions in the Cuban health care sector. Journal of Managed Care Pharmacy.
    6.    Thompson, S.L. & Salmon, J.W. (2016, in preparation).  The medical malpractice insurance crisis. International Journal of Health Services
    7.    Salmon, J.W. & Aruru, M.V. (2016, in preparation).  Health Tourism to India: Challenges against resource competition to sustaining a viable public healthcare infrastructure for the local populace.  International Journal of Health Services
    8.    Aruru, M.V., Salmon, J.W. & Brock, C.M. (2016, in review).  Development of the Pharmacy Inventory, Labeling, and Logistics (PILL) Project in Resource-poor Haiti. International Journal of Health Services
    9.    Salmon, J.W. (2016, in preparation).  The global pharmaceutical industry confronts the 21st century.  International Journal of Health Planning & Management.
    10.    Sanchez, A.M.  & Salmon, J.W.  (2014, in revision).  Cuban pharmacy as it transitions toward a pharmaceutical care model.  International Journal of Pharmacy Practice
    11.    Salmon, J.W. (2014). Global Health Systems.  Journal of Pharmacovigilance. 2:3
    12.    Salmon, J.W. & Aruru, M. (2016, in revision).  Privatization and health/medical tourism in their global trade context.  International Journal of Public Policy
    13.    Thompson, S.L. & Salmon, J.W. (2014). Physician Strikes. Chest: Official Publication of the American College of Chest Physicians. November.
    14.    Salmon, J.W. & Gutkin, D. (2015, in preparation). Japan’s pharmaceutical industry: New developments as it challenges the major global firms. Journal of Managed Care Pharmacy.
    15.    Aruru, M., Salmon, J.W. & Douglas, G.W. (2014). Multiple Sclerosis in India: A qualitative study of access, adherence and other issues in Southern India. Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
    16.    Aruru, M. & Salmon, J.W. (2014). Lessons learned from the Pharmacy pictogram labeling project in Haiti.  Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
    17.    Salmon, J.W. (2013). Medicare Part D & the Federal Employees Benefit Program. American Health & Drug Benefits.   6(1):58.
    18.    Salmon, J.W. & Jiang, R. (2013). E-Prescribing: History, Issues, and Potentials. Online Journal of Public Health Informatics 4(3).
    19.    Aruru, M. V. & Salmon, J.W. (2013). Assessment of Medicare Part D communications to beneficiaries. American Health & Drug Benefits.  3(5):310-317.
    20.    Qato, D., Salmon, J.W. & Lindau, S.T. (2015, in preparation). Racial and ethnic disparities in the use of prescription medications among older adults in the U.S.:  A Population-based approach. 
    21.    Salmon, J.W. & Sanchez, A.M. (2012). Overview of Complementary/Alternative Medicine in the Cuban Health System, International Journal of Healing and Caring 13(1).
    22.    Sanchez, A.M.  & Salmon, J.W.  (2012). Cuban pharmacy in the context of its healthcare system:  Transitioning toward pharmaceutical care practice.  Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
    23.    Salmon, J.W. (2016, in preparation). Obamacare:  The dehiscence of the American health care delivery system.
    24.    Salmon, J.W. (2014, in preparation).  Rising Social Epidemics: Avian flu, SARS & AIDS:  Confronting the infrastructural deficiencies of the public health system in China.  International Journal of Health Services.
    25.    Aruru M, & Salmon J W. (2015, in preparation).   Unrestricted and Uninhibited UV exposure: A case for effective policy standards over the Indoor Tanning Industry.   American Journal of Public Health


    More Info.
    Francis Ignatious
    Senior Scientific Investigator
    Glaxo Smith Kline
    USA
    Francis.2.Ignatious@gsk.com
    IJPSDR
    More Info.
    Wanying Wu
    Professor
    Shanghai Institute of Materia Medica Chinese Institute of Science
    China
    wanyingwu@simm.ac.cn
    IJPSDR

    Research Interest: Molecular Biology, Biotechnology Genetics, Analytical Chemistry.


    More Info.
    Ana Maria Loureiro da Seca
    University of the Azores
    Portugal
    anaseca@uac.pt
    IJPSDR

    Research Interest: Phytochemistry, Natural products, Isolation of Natural Compounds, Structural Elucidation, Chromatographic Techniques, Bioactive Secondary Metabolites.

    More Info.
    View more
    mendeley

    A cross sectional study of alcohol consumption and risk factors

    DOI Logo 10.17352/ijpsdr.000032

    Published On: September 23, 2020 | Pages: 034 - 037

    Author(s): R Dinesh Kumar, J Kalaiselvi and Siva S*
    Abstract View Full Article View
    mendeley

    Developing analytical parameters and evaluation of thermo fisher urinary creatinine enzymatic method to implement in open system chemistry analyzers

    DOI Logo 10.17352/ijpsdr.000031

    Published On: September 16, 2020 | Pages: 030 - 033

    Author(s): Ashraf Mina*, Leah McNeice, Shanmugam Banukumar and Santiago Vazquez
    Abstract View Full Article View
    mendeley

    Development and optimization of mucoadhesive microballons of nizatidine for management of peptic ulcer

    DOI Logo 10.17352/ijpsdr.000030

    Published On: June 29, 2020 | Pages: 021 - 029

    Author(s): Seema Jain, Neha Jain, Mohan Lal Kor, Umesh Kumar Jain and Abhishek Kumar Jain*
    Abstract View Full Article View
    mendeley

    An overview on NMR spectroscopy based metabolomics

    DOI Logo 10.17352/ijpsdr.000029

    Published On: June 03, 2020 | Pages: 016 - 020

    Author(s): Nalini Kanta Sahoo*, G Tejaswini, Madhusmita Sahu and KS Muralikrishna
    Abstract View Full Article View
    mendeley

    Bacteriocin-like protein produced Brevibacillus laterosporus that can inhibit the growth of drug resistant bacteria

    DOI Logo 10.17352/ijpsdr.000028

    Published On: June 03, 2020 | Pages: 012 - 015

    Author(s): Monthon Lertcanawanichakul* and Kittisak Chawawisit
    Abstract View Full Article View
    mendeley

    Pharmaceutical Nanotechnology: A Therapeutic Revolution

    DOI Logo 10.17352/ijpsdr.000027

    Published On: May 05, 2020 | Pages: 009 - 011

    Author(s): Douglas Dourado*
    Abstract View Full Article View
    mendeley

    Regarding the measurement of therapeutic adherence

    DOI Logo 10.17352/ijpsdr.000026

    Published On: April 17, 2020 | Pages: 008 - 008

    Author(s): Sara Malo*
    Abstract View Full Article View
    mendeley

    Jaiphal Myristica fragrans (Houtt)-A promising seed for pharmaceutical industries

    DOI Logo 10.17352/ijpsdr.000025

    Published On: March 21, 2020 | Pages: 006 - 007

    Author(s): Ankita Chakravarty, Jai Gopal Sharma*
    Abstract View Full Article View
    mendeley

    Validation of spectrophotometric method for determination of esomeprazole and ciprofloxacin in their pure and dosage forms

    DOI Logo 10.17352/ijpsdr.000024

    Published On: January 29, 2020 | Pages: 001 - 005

    Author(s): Mohsen M Zareh, Monir Z Saad, Wafaa S Hassan, Mostafa E Elhennawy and Mahmoud M Sebaiy*
    Abstract View Full Article View
    mendeley

    Visible light and UV-assisted photodegradation of phenylephrine by bulk NiO and NiO immobilized on magnetic polypyrrole support

    DOI Logo 10.17352/ijpsdr.000023

    Published On: December 31, 2019 | Pages: 016 - 024

    Author(s): Hossein Faghihian and Firoozeh Torki
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJPSDR